Antitumor efficacy on glioma models of PHA‐848125, a multikinase inhibitor able to cross the blood brain barrier

January 24, 2013, from MedWorm: Brain Tumor

Conclusions & ImplicationsAll the preclinical data obtained so far suggest that PHA‐848125 may become a useful agent in chemotherapy regimens for glioma patients and support its evaluation in phase 2 trials for this indication. (Source: British Journal of Pharmacology)

MedWorm Sponsor Message: Have a look at The Cancer and Oncology Daily, the new cancer portal with all the latest cancer news and research powered by MedWorm, updated daily.

View Source